4
Changes in Ownership
Vistagen Therapeutics, Inc. Filed Acc 0001415889-21-000007
PRES./CHIEF SCIENTIFIC OFFICER acquired 5,000 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| SNODGRASS H. RALPH PRES./CHIEF SCIENTIFIC OFFICER | 2020-12-31 | Grant or award | +5,000 | $0.45 | $2,261 | 87,724 | D |
| Derivatives | |||||||
| SNODGRASS H. RALPH PRES./CHIEF SCIENTIFIC OFFICER | 2020-12-30 | Grant or award · Stock Option (Right to Buy) | +150,000 | 150,000 | D | ||
Loading xslF345X03/form4-01042021_010136.xml…